A private genomic vault and precision copilot designed to support healthier choices and better-informed clinical care—without claiming to replace your doctor.
Start with your perspective
One private foundation · two complementary paths
The same patient-controlled vault could power preventive lifestyle insights and provide relevant genomic context when a clinical decision needs to be made.
Prevent & optimise
Explore lifestyle, nutrition, sleep, exercise and recovery in the context of your biology—without presenting wellness insights as clinical diagnosis.
Personalise care
Help clinicians inspect drug–gene and biomarker factors that may inform treatment, monitoring or recovery planning while retaining clinical judgement.
Your health, on your terms
Holobios Soma is being designed to help you securely bring relevant genetic context into everyday health decisions and clinical conversations.
Join the founding patient cohortSurface genetic factors that may be relevant to how a medicine is activated, transported or cleared, ready to discuss with your clinician.
Explore lifestyle, nutrition, exercise and recovery insights without presenting them as diagnosis or a substitute for care.
Approve time-limited access, share only relevant markers and receive a record of each query.
Holobios Health is an early-stage concept. Its clinical applications would require appropriate evidence, safety review and regulation. It is intended to inform discussion, not make autonomous treatment decisions.
Guidelines protect millions of patients.
Precision context may help explain why individual responses still differ.
Genes can be one factor in how medicines are absorbed, activated or cleared. Personalised care brings that context alongside established guidance, clinical history and professional judgement—not in place of them.
People can respond differently to the same medicine. Genetics may be one useful part of a wider clinical assessment.
Genetic results, medicines, biomarkers and lived experience often sit apart, leaving patients and clinicians to connect them manually.
DNA companies store millions of genomes in central databases. Breaches and bankruptcies put that data at risk.
Case study · Patient Zero
At 31, Tamesh started chemotherapy. Standard care treated his cancer, but persistent effects led him to spend years mapping his genetics, biomarkers and recovery by hand. Holobios Health grew from the question: could that context be made safer and easier to explore with a clinician?
After chemotherapy, the founder experienced persistent kidney phosphate loss and tinnitus. Later genomic exploration raised questions about whether relevant risk factors could have informed monitoring and clinical discussion before treatment.
Some CYP2C19 variants are clinically relevant to activation of clopidogrel. The proposed copilot would surface referenced context for a clinician to assess.
The founder used genomic, biomarker and lifestyle context to form questions about supplement timing during recovery, then tracked his response over time.
Personal data helped the founder explore different training approaches. This experience inspired the platform, but it is not evidence that the same approach suits everyone.
27.2
Biological age at 37
64.7
VO₂ max
5 yrs
Post-chemo monitoring, discharged 2026
Personal observations, shared as the origin story—not clinical validation, a guarantee of outcomes or medical advice.
A conceptual flow. Your genome stays on your phone. Access is requested, and every opening leaves a receipt you can check.
The file is stored on your phone so that if an attacker obtains it, it is unreadable. Technical details will follow under NDA. It is not copied into a central database that we can read.
A clinician requests access when genetic context is relevant to care. How that request is made is still to be confirmed. Nothing is opened unless it is asked for.
Every access leaves a receipt that cannot be changed. At a minimum it records which genes were opened, by whom, when, and what for.
Use that receipt to compare genetic information a practitioner presents in a report or a prescription. It is a second look if something does not match, whoever the mismatch came from.
The exact way a clinician requests access is still being designed. These are the principles that shape it.
A mutually beneficial objective
These are outcomes to test, not savings already proven by Holobios Health. Future pilots should measure clinical utility, recovery experience, workflow time and total cost of care.
Greater agency
Potentially fewer avoidable effects, clearer questions to ask and a better-informed recovery journey.
More usable context
Less manual cross-referencing and concise, inspectable evidence delivered in the flow of care.
Measurable value
An opportunity to study whether preventable complications, treatment interruptions and resource use can be reduced.
We are validating demand before committing to the roadmap. Tell us which version would create real value for you.
For individuals & proactive health
A private, encrypted home for your raw DNA and biological data. Get alerts when a prescribed medicine may not suit your genes, plus holistic vitality insights over time.
For longevity & functional clinics
Patients share genetic markers with your clinic for a consultation, with their consent, and you get clear, referenced guidance in the flow of care.
For clinicians using ambient AI notes
Sits alongside your ambient AI note-taker and quietly flags gene–drug clashes as you prescribe. Zero extra clicks.
For health systems & connected care
Architected around HL7 FHIR and open clinical standards to screen prescriptions against genomic profiles before medications are dispensed, ensuring frictionless adoptability.
Pick every product you'd use and tell us why. Add a refundable £5 deposit to reserve founding access for early 2027, founding-member pricing and a say in what we build.
0
People voted
0
Founding users
Clinicians, researchers, clinics, investors and partners — we'd love to hear from you.